The University of Chicago Medicine has maintained its revered place among academic medical centers due to our long-lasting commitment to superior clinical care, pioneering research and comprehensive surgical education. Since the opening of the original Billings Hospital building in 1927, University of Chicago clinicians and scientists have introduced numerous advances that have fundamentally changed the approach to the care of the surgical patient, including blood transfusion, hormone-based therapy for cancer, organ transplantation, and surgical procedures for peptic gastroesophageal disease.
Every day at the University of Chicago Medicine, Department of Surgery physicians tackle formidable tasks. As clinicians, teachers and researchers, they go to heroic lengths to help patients, train the next generation of physicians and seek innovative cures. These surgeons battle larger-than-life health challenges and take on surgeries that others are reluctant to perform.
They routinely save the day, making enormous strides in advancing knowledge and improving the quality of life for their patients.
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Leading-edge technology. State-of-the-art space optimized for seamless collaborations. Novel treatments and clinical trials. Burgeoning research. For these reasons and more, the Center for Care & Discovery truly serves as a model for future patient care.
In February, Dr. Frim was approached by Dan Kricke, who was born with hydrocephalus and lived his entire life with an implanted shunt. The device diverts excess fluid away from the brain but requires lifelong monitoring and maintenance. Indeed, Mr. Kricke required numerous revision surgeries throughout his life.
When Mr. Kricke met with Dr. Frim, he struggled with concerning symptoms, including consistent pressure in his head, so Dr. Frim suggested an endoscopic third ventriculocisternostomy, a minimally invasive operation in which neurosurgeons create an internal bypass in the brain to reroute excess cerebrospinal fluid. The procedure offers a long-term solution to hydrocephalus. Today, Kricke's headaches are gone, and the shunt is no longer needed and could be surgically removed.
"Our specialists understand the complex nature of congenital anomalies as well as the challenges these patients face as children and as adults," Dr. Frim said. The program includes experts in neurosurgery, neurology, orthopaedic surgery, urology, rehabilitation medicine and genetics.
In addition, the Center for the Surgical Treatment of Obesity was re-designated an Aetna Institute of Quality. The University of Chicago Medicine is the only institution in the Chicagoland area, and one of only a handful of programs nationally, that offers all four minimally invasive bariatric surgeries, including laparoscopic duodenal switch. Patients who qualify for bariatric surgery are supported by our team of experienced surgeons, Vivek Prachand, MD; Mustafa Hussain, MD; and John Alverdy, MD; as well as multidisciplinary experts in nursing, nutrition and psychology. This team approach ensures patients receive the unique treatment they need to acclimate and succeed after surgery.
Along with the Aetna designation, the center holds the American Society for Metabolic and Bariatric Surgery's designation as a Center of Excellence. Our center is one of few obesity surgery programs in the nation that meets the criteria to achieve this important distinction. In the past year, our surgeons have been invited speakers regionally, nationally and internationally, and have been selected to perform live cases broadcast to major surgical regional and international conferences. Taken together, these distinctions acknowledge the collective expertise of our surgeons and staff and the commitment our medical center has toward high-quality care for obese patients.
We are also proud to have been designated as a comprehensive von Hippel-Lindau disease (VHL) Clinical Care Center for children and adults by the nonprofit organization VHL Family Alliance this year. The center was co-founded by Raymon Grogan, MD, and Sarah Nielsen, MS, CGC, genetic counselor. Dr. Grogan and Olufunmilayo I. Olopade, MD, serve as co-directors, while Ms. Nielsen is the center's coordinator. The center includes the expertise of several other physicians in a wide range of subspecialties, including urology, neurosurgery, otolaryngology, gastroenterology, endocrinology, ophthalmology and more.
Our experts develop specialized care plans to meet patients' specific needs, including a comprehensive surveillance plan to screen for early signs of VHL complications, and consultations with our experienced specialists. The center also offers genetic counseling and genetic testing for individuals at risk of VHL due to their personal or family history. Patients can also access resources to learn about and adjust to their new diagnosis.
"Our VHL Center, the only one of its kind in Illinois, is designed to meet a very specific need," Dr. Grogan said. "The multidisciplinary care we provide is the only way to take care of these complex patients.
As soon as they walk through our doors, they're immediately connected to the full array of specialty care they need to live with this disease."
One way our futuristic hospital is revolutionizing healthcare is through the new Comprehensive Listening Center. The first of its kind in the Chicagoland area, the Listening Center brings together experts in the subspecialty areas of cochlear implantation, audiology and surgery to assist patients with inner ear and hearing disorders, including chronic ear infection, vestibular disorders and tumors of the ear and lateral skull base. These programs are supported by our surgeons and allied healthcare professionals, including child life specialists, speech pathologists and audiologists.
With these services housed under one roof, our integrated, multidisciplinary team ensures patients with complex hearing and inner ear disorders receive a comprehensive treatment plan catered to their unique needs and background. The Listening Center is co-directed by Michael Gluth, MD, and Dana Suskind, MD. Another program new to the University of Chicago Medicine is the vascular anomalies group, helmed by Jessica Kandel, MD, professor of surgery, chief of pediatric surgery and surgeon-in-chief of Comer Children's Hospital. The vascular anomalies group is dedicated to the evaluation, treatment and management of vascular birthmarks and tumors of infancy, childhood and adolescence, including hemangiomas and port-wine stains as well as lymphatic, venous and arteriovenous malformations and less common vascular anomalies such as Kaposiform hemangioendothelioma.
Complex diseases like these require intimate collaboration among other pediatric subspecialists, including experts in the fields of cardiology, dermatology, diagnostic radiology, interventional radiology, genetics, neuroradiology, otolaryngology, plastic surgery and oncology. The collective expertise of these physicians sets up the University of Chicago Medicine as the referral site of choice for families whose children have complex vascular anomalies.
"A unique feature of our program is its close integration with our NIH-funded basic science research, which allows us to model vascular malformations and explore potential new treatments in the preclinical phase," Dr. Kandel said. "When promising new approaches are identified, we can rapidly translate them for the benefit of affected children. This important effort allows our group to develop the cuttingedge of care for these patients."
Swati Kulkarni, MD, whose robust research activities focus on breast cancer, received generous federal and non-federal support to continue her studies, all of which would have critical implications in the future care of breast cancer patients. Her NIH-supported studies focus on the effect of flaxseed on breast cancer risk, bariatric surgery and breast cancer risk in postmenopausal women, and the role of estrogen receptor alpha-p53 interaction in resistance to tamoxifen. This year, the section received generous federal and non-federal funding that will support our investigative efforts to understand diseases and improve the outcomes of transplant patients all over the globe. Our research includes studies on infections and the stability of transplantation tolerance as well as randomized clinical trials to test the safety and efficacy of certain medications in pancreatic islet transplantation.
Yolanda Becker, MD, was appointed vice-chair of the OPTN/UNOS Policy Oversight Committee.
Anita Chong, PhD, received $5.6 million in funding from the National Institutes of Health to study "Infections and the Stability of Transplantation Tolerance."
Piotr Witkowski, MD, PhD, received $1.9 million in research funding to assess the safety and efficacy of reparixin in pancreatic islet transplant procedures.
The University of Chicago Medicine hosted a surgical research conference in Beijing. The meeting focused on molecular mechanisms and bioengineering for surgical diseases, and the keynote address was delivered by Jack Gilbert, BSc, PhD, professor and environmental microbiologist at the University of Chicago. 
Urology
The Section of Urology is dedicated to providing the best available care to our patients, generating new medical knowledge and educating the next generation of urology leaders. We are proud to be the leading institution in the state for minimally invasive treatment options of urological cancer and disease. As one of the top urology programs in the country, our surgeons offer specialized expertise across the entire spectrum of urologic care, including urologic oncology, reconstruction, salvage procedures and female urologic surgery, frequently utilizing the most advanced surgical techniques to perform surgery. Indeed, our faculty members are also some of the most experienced robotic surgeons in the nation.
Our urologists also devote much of their efforts to scientific discovery, with a particularly strong research interest in urologic oncology. Currently, our laboratories are combining conventional surgical therapies with standard and experimental adjuvant treatments to improve the understanding of molecular, genetic and biochemical pathophysiologic processes of urological cancers. In addition, our ongoing clinical investigations have focused on quality of life after prostatectomies, the effects of green tea capsules in men with prostate intraepithelial neoplasia and more. While Dr. Song worked the plastic surgery aspect of the medical cases, Dr. Langerman contributed ear, nose and throat expertise, treating hearing problems, tympanic membrane perforations and benign tumors of the head and neck. By joining forces, both surgeons were able to innovatively work together on special cases.
One notable case involved a young man who had suffered an acid burn as a result of a robbery. Along with extensive scarring on his neck and face, the man had a chronic infection in his right ear that caused persistent draining and excessive pain. Dr. Song released the man's scars to give him more mobility, while Dr. Langerman opened the man's ears to release the infection and create a new canal. Together, the surgeons created a stent to ensure that the ear healed properly.
A few months later, Dr. Song and Dr. Langerman followed up with the patient and found he no longer suffered from infections and can now hear.
The Section of Cardiac and Thoracic Surgery showcased their commitment to fight against heart disease in the annual Heart Walk in Grant Park, organized by the American Heart Association. The University of Chicago Medicine was represented by 29 walk teams that raised a grand total of $54,862. Liz Johnson, business administrator, led the section's "Put Your Heart Into It" walk team, whose 16 walkers raised a total of $6,510. Funds raised through the annual Heart Walk benefit groundbreaking research initiatives focused on cardiovascular disease. This year, David Frim, MD, Ralph Cannon Professor and chief of neurosurgery, served as a member of the host committee in charge of organizing A Safe Haven's Holiday Fundraiser. A Safe Haven is a local non-profit organization dedicated to helping people transition from homelessness to sustainability. The Holiday Fundraiser specifically supported homeless veterans.
"Our responsibility as neurosurgeons goes beyond our patients to the entire community that we serve," said Dr. Frim. "Joining our community partners to support their most worthy causes is an imperative."
During the past year, the Section of Vascular Surgery continued its community engagement, with a particular emphasis on patient education. The section provided counseling at the Kidney Fund's "Kidney Action Day," an event coordinated to educate people on kidney disease and prevention. The section also offered patient education and screenings for peripheral arterial disease at the Black Women's Expo and the American Heart Association's Most Powerful Voices Gospel Concert in addition to free abdominal aortic aneurysm and varicose vein screenings right here at the University of Chicago Medicine.
The Section of Urology features its own robust urologic research program with a strong emphasis on oncology. To support the program's research initiatives, the Urinary Tract Team, composed of faculty, staff and families, took their annual run to Wisconsin's Madison Half-Marathon and raised more than $12,600. Additionally, Mohan Gundeti, MD, chief of pediatric urology, participated in "Bike Argentina to Chile," a charity cycling trip that benefits the Urology Foundation. Cyclists, which included medical professionals, cancer survivors, friends and family, cycled for 10 days through Patagonia from Argentina to Chile. This year's ride raised approximately £450,000.
Surgeons across our different sections have also traveled across the world to perform, in many cases, life-changing surgery for children and adults in developing countries.
Fuad Baroody, MD, director of pediatric otolaryngology, and Mark Slidell, MD, assistant professor of pediatric surgery, were invited by John P. Kress, MD, director of intensive care, to perform a case in Haiti. In this case, a girl had choked on a foreign object, which eventually lodged into her lung. Five unsuccessful attempts were made to remove the object Drs. Song and Langerman operating on a patient with a neck tumor in the Dominican Republic.
"Our responsibility as neurosurgeons goes beyond our patients to the entire community that we serve. Joining our community partners to support their most worthy causes is an imperative." "You'll find an abundance of data in other areas of a hospital, but one place where high-quality data is lacking is the operating room," Dr. Langerman said. "OPRI's mission is to set in place a streamlined method of capturing high-quality data in the operating room so surgeons can make better informed decisions that impact efficiency, teaching and patient outcomes."
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To this end, researchers will develop and implement frameworks to improve workflows in operating rooms. Dr. Langerman and his team will also utilize a special investigational technique, known as "dynamic operational mapping," to more deeply understand how surgeons' decisions affect these workflows.
The team is also developing personal video capture systems to allow faculty members to record how these new frameworks improve the surgical experience in real time. "We want to see what the surgeon sees, so we can better understand the daily challenges in the operating room," said Dr. Langerman. These video systems will also provide the ability to record key "teachable moments," which highlight the expertise of the surgical faculty and will have replay capabilities to enhance resident teaching.
Dr. Langerman envisions an OR with ubiquitous datarecording capabilities. "We're finding new ways to utilize sensors in the operating room to capture the day-to-day activities and better understand obstructions to efficient workflow and how to improve patient care." Based on work over the summer, OPRI was recently awarded an early release of the Microsoft Kinect 2.0, an advanced motion capture device, to validate its use in the operating room environment.
In June, OPRI hosted its first annual symposium at the Center for Care & Discovery, which was attended by experts in computer science, social science, medicine, business administration and other fields. The symposium focused on innovative solutions to universal problems in the operating room.
The Section of General Surgery received grant funding from the Graduate Medical Education Committee to develop and implement a five-year curriculum in systems-based practice. The initial implementation of the curriculum included junior residents, who participated in learning sessions, committee work and online forums to discuss systems-based problems.
This year, the curriculum will expand and include project implementation for senior residents. This new feature of the systems-based practice will allow fourth-and fifth-year residents to pick systems-based topics of their choice, such as quality improvement or documentation errors, and work with faculty to implement practical and sustainable solutions to remedy these issues.
The University of Chicago Medicine also hosted its firstever meeting that focused on updates in the study and treatment of thyroid, parathyroid and adrenal diseases. Peter Angelos, MD, chief of endocrine surgery, and Raymon Grogan, MD, director of the endocrine surgery research program, spearheaded the meeting, which was attended by approximately 60 people from the medical community.
Experts across the spectrum of endocrine care presented on a diverse range of topics, including the role of genetic evaluations in treating endocrine tumors and controversial American Thyroid Association guidelines. The speakers also broke into interactive panels, engaging attendees in a constructive discussion on challenging patient cases. Gerard Doherty, MD, James Utley Professor of Surgery and chair of the Department of Surgery at Boston Medical Center, served as the guest faculty member at the meeting. The Department of Surgery is pushing the boundaries of medicine through groundbreaking research. With more than $17 million in annual funding, our scientists are pursuing basic, applied and clinical research projects across a diverse range of topics, including tissue repair and regeneration, new anticancer strategies, vaccines, transplantation, cardiovascular disease, childhood development and innovations in surgical practice. These studies take advantage of the multidisciplinary nature of surgery, as well as the University of Chicago Medicine's culture of tackling some of the most challenging and pressing problems in medicine.
One example of a unique multidisciplinary effort is the collaboration between Joel Collier, PhD, and Anita Chong, PhD, who are combining immunology with bioengineering to develop new molecularly defined vaccine platforms to treat diseases where existing immunotherapy platforms fall short. Their work, which has been supported by the NIH, the Bill and Melinda Gates Foundation and the University of Chicago Women's Board, represents an uncommonly integrated approach to the design of new materials and new vaccines. "Engineers and immunologists collaborate at other institutions, of course, but many other collaborations are set up where the materials are synthesized in one lab and then handed over to the immunologist's group for testing," Dr. Collier said. "Such a unidirectional collaboration is the opposite of what we have built between our groups. For us, a continuous back-and-forth via joint group meetings, co-mentored students and hallway discussions allows us to continuously merge basic studies of immunological mechanisms into design improvements for the technologies."
Successful vaccines have to be designed to interact with the immune system so that they elicit the appropriate protective response without any adverse affects. To achieve this response, vaccines must contain several components, including parts of the microbe that can be recognized by the immune system (antigens), plus other molecules that call the immune system into action (adjuvants). Vast strides are being made in identifying specific antigens for vaccines, but adjuvants capable of tuning the type of immune response that is generated have been harder to achieve. Collier and Chong have developed "self-adjuvanting" materials, where antigens "self-assemble" into nanoparticles and nanofibers when they are mixed in solution. Because the materials are designed and produced by Collier's group, they can be engineered and improved as details of their mechanism of action are discovered. These new platforms are now enabling the development of strategies for treating diseases previously intractable to vaccination, as well as conditions not usually thought to be within the purview of vaccines. "Our collaboration can provide insights into how biomaterials interact with the immune system," Dr. Chong
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said. "Maximizing this interaction may lead to a new class of self-adjuvanting vaccines, while conversely, minimizing or shaping the interaction may result in biomaterials that are optimized for wound healing and repair."
Collier and Chong are part of a growing effort at the University of Chicago Medicine to develop immunologically active materials. In a collaboration with Matt Tirrell, PhD, director of the Institute for Molecular Engineering, Collier and Chong are conducting a project to understand how the physical characteristics of nanomaterials contribute to some of their unique immunological properties. This team is also working to change the way vaccines are distributed across the globe. Presently, all vaccines must be shipped and stored at tightly controlled refrigerated temperatures. Many developing countries, especially those in the tropics, lack the ability to consistently maintain this "cold chain" all the way to the patient, so the effectiveness of many vaccines is compromised in the locations that most desperately need them. To address this shortcoming, Collier and colleagues are exploiting and expanding the thermal and environmental stability of their materials-based vaccines, in a project funded by The Bill and Melinda Gates Foundation.
The work of Dana Suskind, MD, professor of surgery and co-director of the Comprehensive Listening Center, is an example of the immediate impact that research in the department is achieving. Dr. Suskind has been expanding her Thirty Million Words (TMW) Initiative, which takes its name from previous research showing that economically disadvantaged children hear 30 million fewer words by the age of three compared with children in wealthier communities. TMW is a parent-directed, parent-tested initiative designed to close this gap through parent-child interaction. Its 12-week curriculum employs animation and video modeling to build daily behaviorchanging strategies for participants. Through a less invasive technique that utilizes a tiny catheter to find the malformation, Drs. Awad and Lee were able to successfully cure Davis' fistula by blocking the connection with medical superglue and even uncover the rare blood-clotting tendency that had caused his condition. As a demonstration of their gratitude, the Davis family contributed $1 million to establish the Judy and Bill Davis Research Fund in Neurovascular Surgery, allowing Dr. Awad to expand research efforts and, in turn, make an impact on future patients with neurovascular diseases.
Die-hard White Sox fan Frank Smith also found hope for his lung cancer at the University of Chicago Medicine in Mark Ferguson, MD, and Ravi Salgia, MD, PhD. Smith, who was previously misdiagnosed by two outside physicians, was fully aware of his family's history with cancer and believed his chances were grim. However, after months of chemotherapy, radiation therapy and surgery for his cancer at the University of Chicago Medicine, Smith felt he was truly cared for by his doctors every step of the way.
"We always felt like these physicians were right there for us," Smith's wife, Jan, said. "I've worked in doctors' offices my whole life, but the doctors at the University of Chicago gave us their phone numbers and their e-mail addresses. I had never seen that before."
Now in remission, the Smiths have committed to supporting Dr. Ferguson's research. Their gifts will help physicians-intraining investigate the fundamentals of cancer causation and treatment.
There are many ways you can be involved with advancing the goals of the Department of Surgery. For more information on how you can join us or make a gift, please contact:
